Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

4 points crucial to the nimble regulation of GenAI
With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.
FDA recalls infant incubators due to risk of door falling off
A loose screw on the Giraffe OmniBed is to blame. With updated use instructions and repairs, the incubators are safe to use.
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.
Kentucky AG launches criminal probe after conscious man nearly has organs harvested
Three years ago Anthony Hoover was declared brain dead—until he woke up on the operating room table, moments before his organs were removed. His story has spurred a criminal investigation by Kentucky's attorney general.
FDA announces Class I recall of ventilators after 3 patient injuries
An unexpected nickel coating on the breathing circuits of Percussionaire Phasitron 5 ventilators is being blamed for the recall. The FDA is asking providers to stop using them immediately.

Private equity has a role in increasing healthcare prices

The healthcare space has seen an influx of investment from private equity groups looking to innovate the market, but the role of these investors could also be pushing healthcare prices higher.

October 31, 2019

Pelosi plan to lower drug prices faces political challenges

House Speaker Nancy Pelosi’s (D-CA) bill to lower drug prices is facing new challenges as congressional Democrats debate changes to the plan, The Hill reported.

October 30, 2019

Walgreens changes in-store clinic strategy with closures, partnerships

Walgreens is switching up its approach to in-store clinics, closing the clinics it operates and keeping those run by other health systems.

October 30, 2019

Americans are split on healthcare reform plans

Americans are split across healthcare reform options, according to a recent survey, revealing that many are dissatisfied with the current healthcare system but don’t agree on how to improve it.

October 30, 2019

Some Americans avoid healthcare because they don’t understand insurance

Lack of understanding about healthcare insurance is impacting the health of Americans.

October 29, 2019

States prep for loss of ACA

Several states are working on their own healthcare plans to preserve some coverage and provisions of the Affordable Care Act as the healthcare law makes its way through an appeals court and faces the real possibility of being overturned, The Wall Street Journal reported.

October 25, 2019

AI’s effect on healthcare could be transformative—but it will need some help

As AI technologies continue to evolve, they could have a titanic impact on the health of people all over the world, improving patient outcomes and changing the way each and every person lives their life. It’s going to take more than just AI alone, however—there are a number of other factors to consider as well.

October 24, 2019

FTC to study the impact of hospital, health system mergers

The Federal Trade Commission has taken special interest in mergers and acquisitions in the healthcare space and the role increasingly bigger companies play when it comes to healthcare costs and quality of services.

October 24, 2019

Around the web

AI in Healthcare

4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular Business

Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.

Cardiovascular Business

Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.